PRE-EMPTIVE OR PROPHYLACTIC THERAPY FOR REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WHO RECEIVED IMMUNOSUPPRESSIVE OR CYTOTOXIC THERAPY: EVALUATION OF BOTH HBsAg-POSITIVE AND HBsAg-NEGATIVE COHORTS

被引：0
|
作者：
Tamori, A. [1 ]
Koike, T. [1 ]
Goto, H. [1 ]
Tada, M. [1 ]
Morikawa, H. [1 ]
Enomoto, M. [1 ]
Nakatani, T. [1 ]
Hino, M. [1 ]
Kawada, N. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60433-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
431
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [31] Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period
    Iwai, K
    Tashima, M
    Itoh, M
    Okazaki, T
    Yamamoto, K
    Ohno, H
    Marusawa, H
    Ueda, Y
    Nakamura, T
    Chiba, T
    Uchiyama, T
    BONE MARROW TRANSPLANTATION, 2000, 25 (01) : 105 - 108
  • [32] Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period
    K Iwai
    M Tashi
    M Itoh
    T Okazaki
    K Yamamoto
    H Ohno
    H Marusawa
    Y Ueda
    T Nakamura
    T Chiba
    T Uchiya
    Bone Marrow Transplantation, 2000, 25 : 105 - 108
  • [33] The role of hepatitis B core-related antigen in predicting HBV reactivation among HBsAg-negative, anti-HBc-positive individuals undergoing immunosuppressive therapy
    Seto, Wai-Kay
    Wong, Danny
    Liu, Sze Hang Kevin
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    HEPATOLOGY, 2015, 62 : 966A - 966A
  • [34] AntineoplasticsFatal reactivation of hepatitis B virus infection in a HBsAg-negative and anti-HBc-positive patient: case report
    Reactions Weekly, 2009, 1273 (1) : 7 - 8
  • [35] Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis
    Tien, Y. -C.
    Yen, H. -H.
    Chiu, Y. -M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 831 - 836
  • [36] The Risk of Hepatitis B Virus Reactivation in HBsAg-Negative and Anti-HBc-Positive Patients Receiving Tumor Necrosis Factor Antagonists
    Pauley, Mary Patricia
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 210 - 211
  • [37] Effect of Glucocorticoid on Hepatitis B Virus Reactivation in HBsAg-positive Rheumatoid Arthritis Patients undergoing Biologics Treatment
    Chen, Ming-Han
    Tsai, Chang-Youh
    Chou, Chung-Tei
    Lin, Hsiao-Yi
    Lee, Mei-Hsuan
    Huang, Yi-Hsiang
    HEPATOLOGY, 2016, 64 : 899A - 900A
  • [38] Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy?
    Papamichalis, Panagiotis
    Alexiou, Alexis
    Boulbou, Maria
    Dalekos, George N.
    Rigopoulou, Eirini I.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (01) : 84 - 93
  • [39] Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
    Ya-Chih Tien
    Hsu-Heng Yen
    Ching-Fang Li
    Mei-Ping Liu
    Yin-Tzu Hsue
    Ming-Hui Hung
    Ying-Ming Chiu
    Arthritis Research & Therapy, 20
  • [40] Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
    Tien, Ya-Chih
    Yen, Hsu-Heng
    Li, Ching-Fang
    Liu, Mei-Ping
    Hsue, Yin-Tzu
    Hung, Ming-Hui
    Chiu, Ying-Ming
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
12345